Neoadjuvant Lenvatinib and Pembrolizumab for IVC Tumor Thrombus
Clinical trial NCT05319015 · RECRUITING
Trial details
- NCT number
- NCT05319015
- Sponsor
- University of Texas Southwestern Medical Center
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-06
- Primary completion
- 2026-07-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.